Dr. Dezawa MUSE Cells Vs. MSCs Ratios Matter

Join Dr. Mari Dezawa, the pioneering discoverer of Multilineage-differentiating Stress-Enduring (MUSE) cells, as she breaks down a game-changing insight into these revolutionary endogenous stem cells. In this exclusive interview, Dr. Dezawa explains why, in enriched MUSE cell preparations, When 70% or more MUSE cells are used they exhibit the full pluripotent prowess. If less than 70% used then they act like Mesenchymal stem cells (MSCs). So MSCs and MUSE cells can’t be mixed and applied.—homing to damaged tissues, differentiating into all three germ layers without tumor risk, and driving superior regeneration. Meanwhile, the lower percentage? They function more like conventional Mesenchymal Stem Cells (MSCs), offering supportive but limited repair.
Discover how this purity threshold transforms regenerative medicine for conditions like stroke, liver injury, and spinal cord damage. From accidental discovery in 2010 to cutting-edge clinical trials, Dr. Dezawa shares the science, challenges, and future of MUSE cells as the "missing link" in stem cell therapy.

If you're passionate about biotech breakthroughs, hit LIKE, SUBSCRIBE, and turn on notifications for more stem cell deep dives!
Explore MUSE cell research: www.dbcmusecells.com

Call (888) 704-3977 for a free MUSE Cell Consultation